SEC Form 4 · accession 0001645627-17-000048
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 27, 2017
Accepted (ET)
May 2, 2017 · 10:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0799 | A | 20,450,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,451,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0788 | A | 20,452,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,453,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0778 | A | 20,454,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,455,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,456,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,457,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.078 | A | 20,458,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.078 | A | 20,459,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,460,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0788 | A | 20,461,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,462,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,463,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,464,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,465,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,466,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.079 | A | 20,467,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0848 | A | 20,468,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0828 | A | 20,469,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0827 | A | 20,470,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.083 | A | 20,471,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,472,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,473,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,474,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,475,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,476,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,477,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0842 | A | 20,478,449 | D | |
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0845 | A | 20,479,449 | D |
Table II — derivative securities
No Table II lines on this filing.